Study | Random Adequate (A) | Allocation Concealed (B) | Patient Blind (C) | Care Provider Blind (D) | Assessor Blind (E) | Dropouts (F) | All Analyzed (G) | Selective outcome (H) | Baseline Similar (I) | Cointervention Avoided (J) | Compliance Acceptable (K) | Timing of Outcome (L) | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Braker32 | ? | ? | + | + | + | + | 0 | ? | ? | + | + | + | 7 |
Carroll33 | + | ? | + | + | + | 0 | ? | ? | + | ? | + | + | 7 |
Cheshire23 | ? | ? | + | ? | ? | + | + | ? | + | + | + | + | 7 |
Esenyel24 | 0 | 0 | 0 | 0 | 0 | + | + | ? | ? | ? | ? | + | 3 |
Ferrante25 | + | + | + | + | + | ? | + | ? | + | + | ? | + | 9 |
Freund35 | + | + | + | + | ? | + | 0 | ? | 0 | ? | + | + | 7 |
Gobel26 | + | + | + | + | + | + | 0 | ? | + | 0 | 0 | + | 8 |
Kamanli27 | ? | 0 | 0 | 0 | 0 | 0 | + | 0 | + | ? | + | + | 4 |
Lew28 | + | + | + | + | + | 0 | 0 | ? | 0 | ? | + | + | 7 |
Ojala29 | ? | ? | ? | ? | ? | + | ? | ? | 0 | + | + | + | 4 |
Padberg34 | ? | + | + | + | + | + | + | ? | + | ? | + | + | 9 |
Schnider31 | ? | ? | ? | ? | + | 0 | ? | ? | + | + | + | + | 5 |
Wheeler30 | ? | ? | + | + | + | 0 | + | ? | 0 | 0 | + | + | 6 |
Wheeler36 | 0 | + | + | + | + | 0 | 0 | ? | 0 | ? | + | + | 6 |
Totals, n = 14 (%) | 5 (36) | 6 (43) | 10 (71) | 9 (64) | 9 (64) | 7 (50) | 6 (43) | 0 (0) | 7 (50) | 5 (36) | 11 (79) | 14 (100) | |
Weighted κ | 0.4731 | 0.7154 | 0.7529 | 0.9412 | 0.6067 | 0.2317 | 0.7200 | 0 | 0.2446 | 0.3069 | 0.8923 | 1.0000 |
+: yes, item adequately addressed; 0: no, not adequately addressed; and ?: unsure if adequately addressed. A: Was the method of randomization adequate? B: Was the treatment allocation concealed? C: Was the patient blinded to the intervention? D: Was the care provider blinded to the intervention? E: Was the outcome assessor blinded to the intervention? F: Was the dropout rate described and acceptable? G: Were all randomized participants analyzed in the group to which they were allocated? H: Are the reports of the study free of suggestion of selective outcome reporting? I: Were the groups similar at baseline regarding the most important prognostic indicators? J: Were cointerventions avoided or similar? K: Was the compliance acceptable in all groups? L: Was the timing of the outcome assessment similar in all group?